Anthony Curtis

Dr Anthony Curtis is a Senior Lecturer in Organic and Medicinal Chemistry at the School of Pharmacy and Bioengineering, Keele University. With a career spanning over 25 years at Keele, he has played a pivotal role in developing the MPharm program and advancing nanopharmaceutical research.

• Current focus on nanopharmaceutics and supramolecular delivery systems
• Collaborates with Dr Alan Richardson (Keele), Dr Jóhannes Reynisson (Keele), and Dr Clare Hoskins (University of Strathclyde)
• External Examiner for MPharm at Robert Gordon University

His research addresses critical challenges in drug delivery through nanotechnology-enabled solutions, particularly for hydrophobic anticancer drugs. He has pioneered the use of calix[n]arenes and calix[4]resorcinarenes as solubilizing agents for creating responsive nano-carriers that release drugs under specific stimuli like pH changes.

Recent publications demonstrate his work's impact across multiple subfields:

• Pancreatic cancer nanotherapy
• Thermoresponsive drug carriers
• Hybrid nanoparticle design
• Prodrug chemistry
• Controlled release mechanisms
• Anti-microbial resistance solutions

Awarded:

• Keele University Excellence in Learning and Teaching Award (2008)
• Institute of Science and Technology in Medicine Research Fellowship (2015-2016)

Professional memberships include: Royal Society of Chemistry (Fellow and Chartered Chemist), American Chemical Society, Academy of Pharmaceutical Sciences, and UK/Ireland Controlled Release Society.